Combination of Bortezomib in the Induction, Conditioning and Consolidation With Autologous Hematopoietic Stem Cell Transplantation in Patients With Immunoglobulin Light Chain Amyloidosis
American Journal of Hematology- United States
doi 10.1002/ajh.25404
Full Text
Abstract
Available in
Categories
Date
February 4, 2019
Authors
Publisher
Wiley